Company / Cost of Revenue
INSMED Inc Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$122.9M
FY2025
5-year range
$44.2M / $122.9M
FY2021-FY2025
Trend
+43.4%
vs FY2024
Sector context
#42 of 85
Health Care
What the data says
At $123M, INSMED Inc's cost of revenue ranks #44 of 85 in the Health Care sector. Cost of Revenue has increased for 8 consecutive years, from $0 in FY2017 to $123M in FY2025.
Based on SEC 10-K filings.
$123M in FY2025 with a 5-year CAGR of +25.3%.
Increased from $66M to $123M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +30.7%
- 5-Year CAGR
- +25.3%
- 10-Year CAGR
- -
Sector benchmark
#44 of 85 in Health CareTop 51% of 85This company $122.9M Sector average $2.0B
▼
-93.8% below sector average
Key checks
Key Insights
- INSMED Inc's cost of revenue has grown for 7 consecutive years.
- 5-year CAGR of +25.3%, indicating consistent growth.
- In FY2025, cost of revenue increased 43.4% year-over-year.
- Ranks #42 out of 85 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $122.9M | +43.4% |
| FY2024 | $85.7M | +30.8% |
| FY2023 | $65.6M | +19.0% |
| FY2022 | $55.1M | +24.9% |
| FY2021 | $44.2M | +10.7% |
| FY2020 | $39.9M | +64.7% |
| FY2019 | $24.2M | +899.3% |
| FY2018 | $2.4M | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026